Pancreatic Cancer Research

ResearcherEast China Normal UniversityActive in the last 2 years

Chen Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2507-5044; OpenAlex author ID A5022523151. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 4

  1. Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment. Co-author DOI 10.1021/acscentsci.3c01440↗
  2. Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Co-author DOI 10.1038/s41388-024-03044-x↗
  3. Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-22-0997↗
  4. Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Co-author DOI 10.1038/s41388-020-01626-z↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mingyao Liu · 4 shared papers, 2021–2024 · strength 0.66
  2. Zhengfang Yi · 4 shared papers, 2021–2024 · strength 0.66
  3. Zhenliang Sun · 2 shared papers, 2023–2024 · strength 0.34
  4. Yihua Chen · 2 shared papers, 2023–2024 · strength 0.34
  5. Peng He · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.